Allergy

Data supported selection of EP262 as a potent, highly selective development candidate Clinical development of EP262 recently initiated as a novel treatment for a broad range of mast cell mediated diseases including chronic spontaneous…

<!-- Name:DistributionId Value:1000780654 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

– Results show the impact of attacks on mental health, daily activities, and quality of life in people living with HAE - – Real-world data demonstrate treatment burden associated with on-demand parenteral HAE therapies - CAMBRIDGE,…